This week, from Wednesday November 7 through Sunday November 11, Akron Biotech representatives will be attending the Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting at the Walter E. Washington Convention Center in Washington, D.C. SITC 2018 is the leading destination for scientific exchange, education and networking in the cancer immunotherapy field.
As an innovative company that develops, manufactures and markets ancillary materials, Akron Biotech provides the highest quality of cGMP cytokines and growth factors in the market to support your immunotherapy needs.
Want to learn more about how Akron can improve your process?
Representatives from Akron will be in attendance. Come meet us at Exhibit #108. See you soon!